(IN BRIEF) Researchers at the Paul Scherrer Institute PSI have developed the world’s first achromatic lens for neutron imaging, a breakthrough that allows neutrons of different wavelengths to be focused at the same point. The lens enables sharp, magnified images … Read the full press release →
Posted in Industrial, Science, Switzerland, Technology
Tagged achromatic neutron lens, Achromatic Neutron Lens Could Transform Imaging Inside Complex Materials and Equipment, cryostats, diamond structures, diffraction, electron-beam lithography, European Spallation Source, furnaces, Future technologies, Joan Vila-Comamala, lithium-ion battery imaging, Mano Raj Dhanalakshmi Veeraraj, materials science, nanofabrication, nanotechnology, Nature Communications, neutron beam, neutron imaging, neutron microscopy, neutron wavelengths, New Neutron Lens Opens Path to Sharper Imaging of Batteries Engines and Thick Samples, nickel rings, Paul Scherrer Institute, PICO cleanroom, pressure cells, PSI, PSI Breakthrough Brings Neutrons Into Sharper Focus for Advanced Materials Imaging, refraction, SINQ, SLS, Sweden, Swiss Light Source, Swiss Spallation Neutron Source, SwissFEL, Switzerland, SYNOVA S.A., X-ray optics
(IN BRIEF) Researchers at the Paul Scherrer Institute have identified the molecular mechanism behind a light-switchable drug that can modulate its effectiveness in treating high blood pressure. By observing how the compound changes shape and interacts with its receptor, the … Read the full press release →
Posted in Business, Energy, Gas & Oil, Healthcare, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged beta blockers, biomedical innovation, Consejo Superior de Investigaciones Científicas, drug design, High blood pressure, Jörg Standfuss, leadXPro, light switchable drugs, molecular research, Paul Scherrer Institute, photoazolol 1, photopharmacology, precision medicine, PSI, PSI Researchers Reveal Molecular Mechanism Behind Light Switchable Blood Pressure Drug, PSI Unlocks New Insights into Precision Medicine Through Light Activated Drug Innovation, Quentin Bertrand, SwissFEL, targeted therapy, β adrenergic receptors
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
